2026 program planning committee
Aaron Hoskins
- Co-chair
- University of Wisconsin–Madison
Sandra Gabelli
- Co-chair
- Merck & Co.
Rozalyn Anderson
- University of Wisconsin–Madison
Michelle Arkin
- University of California, San Francisco
Allison Augustus–Wallace
- LSU Health Sciences Center New Orleans
Keriann Backus
- University of California, Los Angeles
Basudeb Bhattacharyya
- University of Wisconsin–La Crosse
J. Martin Bollinger Jr.
- Penn State University
Mario J. Borgnia
- National Institute of Environmental Health Sciences
Shyretha Brown
- Building Bridges Inc.
Charles Burant
- University of Michigan
Isabel Casas
- ASBMB
Luisa Cochella
- Johns Hopkins University School of Medicine
Philip Cole
- Brigham and Women’s Hospital/Harvard Medical School
Matthew Disney
- University of Florida/Scripps Institute for Biomedical Research & Innovation
Oluwarotimi (Timi) Folorunso
- McLean Hospital/Harvard Medical School
Polly Fordyce
- Stanford University
Mario Halic
- St. Jude's Children’s Research Hospital
Michelle L. Hastings
- University of Michigan Medical School
Rinku Jain
- AbbVie Inc.
Daniel Jarosz
- Stanford University
Graham T. Johnson
- Allen Institute for Cell Science
Greg Lohman
- New England Biolabs
Stefan Lutz
- Codexis Inc.
Gary J. Patti
- Washington University in St. Louis
Alberto Rascon
- Arizona State University
Tânia Reis
- University of Colorado, Anschutz Medical Campus
Jenna Roecklein–Canfield
- Simmons University
Harini Sampath
- Rutgers University
Sujata Sharma
- Johnson & Johnson
Hua Su
- Merck & Co.
Fred Vaillancourt
- Remix Therapeutics Inc.
Kevin Welsher
- Duke University
Hongyuan (Rob) Yang
- University of Texas Health Science Center at Houston
Jin Zhang
- University of California, San Diego